2023-05-04 12:40:44 ET
- Amneal Pharmaceuticals ( NYSE: AMRX ) is scheduled to announce Q1 earnings results on Friday, May 5th, before market open.
- The consensus EPS Estimate is $0.10 (-16.7% Y/Y) and the consensus Revenue Estimate is $542.18M (+9.0% Y/Y).
- Over the last 2 years, AMRX has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 2 upward revisions and 0 downward.
For further details see:
Amneal Pharmaceuticals Q1 2023 Earnings Preview